DE3024304C2 - - Google Patents

Info

Publication number
DE3024304C2
DE3024304C2 DE3024304A DE3024304A DE3024304C2 DE 3024304 C2 DE3024304 C2 DE 3024304C2 DE 3024304 A DE3024304 A DE 3024304A DE 3024304 A DE3024304 A DE 3024304A DE 3024304 C2 DE3024304 C2 DE 3024304C2
Authority
DE
Germany
Prior art keywords
general formula
group
hydrogen atom
rifamycin
formylrifamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3024304A
Other languages
German (de)
English (en)
Other versions
DE3024304A1 (de
Inventor
Renato Varese It Cricchio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GRUPPO LEPETIT SpA MAILAND/MILANO IT
Original Assignee
GRUPPO LEPETIT SpA MAILAND/MILANO IT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GRUPPO LEPETIT SpA MAILAND/MILANO IT filed Critical GRUPPO LEPETIT SpA MAILAND/MILANO IT
Publication of DE3024304A1 publication Critical patent/DE3024304A1/de
Application granted granted Critical
Publication of DE3024304C2 publication Critical patent/DE3024304C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE19803024304 1979-06-28 1980-06-27 Wasserloesliche hydrazone von 3- formylrifamycin sv Granted DE3024304A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922461 1979-06-28

Publications (2)

Publication Number Publication Date
DE3024304A1 DE3024304A1 (de) 1981-02-05
DE3024304C2 true DE3024304C2 (en, 2012) 1991-10-31

Family

ID=10506154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803024304 Granted DE3024304A1 (de) 1979-06-28 1980-06-27 Wasserloesliche hydrazone von 3- formylrifamycin sv

Country Status (18)

Country Link
US (1) US4271155A (en, 2012)
JP (1) JPS5618993A (en, 2012)
KR (1) KR830002533B1 (en, 2012)
AR (1) AR225181A1 (en, 2012)
AU (1) AU536524B2 (en, 2012)
CA (1) CA1114814A (en, 2012)
DE (1) DE3024304A1 (en, 2012)
DK (1) DK155742C (en, 2012)
FR (1) FR2460304A1 (en, 2012)
GB (1) GB2051815B (en, 2012)
HK (1) HK23684A (en, 2012)
IE (1) IE49930B1 (en, 2012)
IT (1) IT1209333B (en, 2012)
NL (1) NL8003527A (en, 2012)
NZ (1) NZ194144A (en, 2012)
PH (1) PH15769A (en, 2012)
SE (1) SE451842B (en, 2012)
ZA (1) ZA803635B (en, 2012)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096285A2 (en) * 2003-04-25 2004-11-11 Gilead Sciences, Inc. Anti-infective phosphonate conjugates
KR101327635B1 (ko) * 2005-08-11 2013-11-12 타간타 테라퓨틱스 인크. 포스폰산화 리파마이신, 및 그의 뼈 및 관절 감염의 저지및 치료 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (en, 2012) * 1964-07-31
FR5223M (en, 2012) * 1965-11-12 1967-07-10
US4005076A (en) * 1971-06-24 1977-01-25 Gruppo Lepetit S.P.A. Hydrazones of 3-formylrifamycin SV
BE794100A (fr) * 1972-02-23 1973-05-16 Lepetit Spa Derives 3-hydrazonomethyles de rifamycine et leur preparation
AR205434A1 (es) * 1972-03-27 1976-05-07 Lepetit Spa Proceso para la preparacion de 3-acilhidrazonometil rifamicinas sv
GB1486118A (en) * 1975-03-05 1977-09-21 Lepetit Spa Rifamycin derivatives
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
GR64108B (en) * 1977-04-15 1980-01-24 Dso Pharmachim Method for the preparation of azomethine-derivatives of rifamycin s.v

Also Published As

Publication number Publication date
DK269380A (da) 1980-12-29
GB2051815A (en) 1981-01-21
FR2460304B1 (en, 2012) 1984-07-27
HK23684A (en) 1984-03-23
AU5918880A (en) 1981-01-08
IE49930B1 (en) 1986-01-08
US4271155A (en) 1981-06-02
DK155742C (da) 1989-09-18
DE3024304A1 (de) 1981-02-05
SE8004739L (sv) 1980-12-29
DK155742B (da) 1989-05-08
KR830002767A (ko) 1983-05-30
GB2051815B (en) 1983-07-06
KR830002533B1 (ko) 1983-11-12
JPS6348877B2 (en, 2012) 1988-09-30
NZ194144A (en) 1984-05-31
IT1209333B (it) 1989-07-16
ZA803635B (en) 1981-06-24
JPS5618993A (en) 1981-02-23
AU536524B2 (en) 1984-05-10
FR2460304A1 (fr) 1981-01-23
CA1114814A (en) 1981-12-22
IE801346L (en) 1980-12-28
AR225181A1 (es) 1982-02-26
SE451842B (sv) 1987-11-02
PH15769A (en) 1983-03-24
NL8003527A (nl) 1980-12-30
IT8022817A0 (it) 1980-06-17

Similar Documents

Publication Publication Date Title
CH648037A5 (de) Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
DE3131365A1 (de) Neue diglycidyl-substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen mit cytostatischer wirksamkeit
DD203052A5 (de) Verfahren zur herstellung von 9-(1,3-dihydroxy-2-propoxy-methyl)-guanin, dessen salzen und bestimmten benzylderivaten desselben
DE1795763A1 (de) Verfahren zur herstellung von desacylierten vielkernigen indolverbindungen sowie deren estern
DE2433105C2 (en, 2012)
DE2332485C2 (de) Gentamicin C1-derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1906527C3 (de) Thioninderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, welche diese enthalten
DE1595876A1 (de) Verfahren zur Herstellung von Aminomethylderivaten von Rifamycin SV
DE2826546C2 (en, 2012)
DE2509260C3 (de) a-(23,43,6-Penta-O-acetyl-D-gluconyl-thioureido)benzylpenicillin
DE2119964B2 (de) Methyl-n-(n'-methyl-n'-nitrosocarbamoyl)-d-glycosaminid und verfahren zu dessen herstellung
DE3024304C2 (en, 2012)
DE3035259C2 (de) Cephalosporinverbindungen, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten
DE3531453A1 (de) Substituierte 7-oxomitosan-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel
AT394724B (de) Verfahren zur herstellung von n7-amidino-substituierten mitomycin-c-derivaten
DE2552289C2 (de) Chinoxalin-1,4-dioxydderivate sowie diese enthaltende Arzneimittel und Beifuttermittel und Verfahren zur Herstellung derselben
DE3302699A1 (de) N-methansulfonsaeure-derivate von 3-0-demethylistamycin b und verfahren zu ihrer herstellung
DE2147857C2 (de) Substituierte 6-Phenyl-imidazo[2,1-b]-thiazole, Verfahren zu ihrer Herstellung und sie enthaltende anthelmintische Mittel
DE2857816C2 (de) 7ß-(substituierte-Isothiazol)thioacetamido-7-methoxy(alkylsubstituierte-tetraz olyl)thiomethyl-Δ↑3↑-cephem-4-carbonsäuren, Verfahren zu ihrer Herstellung und deren Verwendung
DE1912941B2 (de) 1 -PhenyM-amino-e-methoxypridaziniumsalze
DE2230003A1 (de) Neue nitrosoharnstoffderivate
CH516593A (de) Verfahren zur Herstellung von neuen Estern von a-Aminobenzyl-penicillin
DE1545838C3 (de) 7-(2-Azidooctanamido)-cephalosporansäure, deren Salze und Verfahren zur Herstellung dieser Verbindungen
DE2458257C2 (de) 1'-Desmethyl-1'-(β-hydroxyäthyl)-clindamycin-2-phosphat, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
AT399339B (de) Verfahren zur herstellung von teilweise neuen substituierten 7-oxomitosanen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P.,

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT. RAUH, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee